» Articles » PMID: 12615308

Hantavirus

Overview
Journal Antiviral Res
Publisher Elsevier
Date 2003 Mar 5
PMID 12615308
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

When hantaviruses hit the headlines with the advent in May 1993 of a new disease in the USA, and later in the New World from Canada to south Argentina, called "hantavirus pulmonary syndrome" (HPS), speculations in the lay press rose from the very beginning around the possibilities of a biological warfare (BW) weapon. Indeed, the responsible agent of HPS, hantavirus, was almost unknown at that moment in the New World, was airborne, seemed to target preferentially young adults, and induced a devastating cardio-pulmonary collapse with a high case-fatality rate (50%), often within hours. It quickly became clear, however, that the same scourge had been known for many years in the Old World under different and mostly milder presentations. With the rapidly increasing knowledge about hantaviruses, it also became clear that they lack many of the potentials of an "ideal" BW weapon, as will be explained in this paper.

Citing Articles

Survey of rodent-borne pathogens in Singapore reveals the circulation of Leptospira spp., Seoul hantavirus, and Rickettsia typhi.

Griffiths J, Yeo H, Yap G, Mailepessov D, Johansson P, Low H Sci Rep. 2022; 12(1):2692.

PMID: 35177639 PMC: 8854382. DOI: 10.1038/s41598-021-03954-w.


Advances in the Development of Phage-Based Probes for Detection of Bio-Species.

Paramasivam K, Shen Y, Yuan J, Waheed I, Mao C, Zhou X Biosensors (Basel). 2022; 12(1).

PMID: 35049658 PMC: 8773867. DOI: 10.3390/bios12010030.


Improving the precision of modeling the incidence of hemorrhagic fever with renal syndrome in mainland China with an ensemble machine learning approach.

Ye G, Alim M, Guan P, Huang D, Zhou B, Wu W PLoS One. 2021; 16(3):e0248597.

PMID: 33725011 PMC: 7963064. DOI: 10.1371/journal.pone.0248597.


Biodefense Implications of New-World Hantaviruses.

DSouza M, Patel T Front Bioeng Biotechnol. 2020; 8:925.

PMID: 32850756 PMC: 7426369. DOI: 10.3389/fbioe.2020.00925.


Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES).

De Clercq E Adv Antivir Drug Des. 2020; 5:59-112.

PMID: 32288473 PMC: 7146830. DOI: 10.1016/S1075-8593(06)05002-7.